Introduction
Ras proteins act as on/o switches that regulate signal transduction pathways controlling cell growth, dierentiation, and survival (Boguski and McCormick, 1993; Downward, 1998; Lowy and Willumsen, 1993; Schlessinger and Ullrich, 1992; Shields et al., 2000) . They are anchored to the inner surface of the cell membrane, where membrane receptors induce the conversion of inactive Ras-GDP to active Ras-GTP (GDP/GTP exchange) and inactivation of Ras-GTP (stimulation of Ras GTPase activity) (Bourne et al., 1991; Schezek et al., 1997) . As many as 30% of all human tumors express mutated Ras proteins (Bos, 1989) without GTPase activity (Schezek et al., 1997) . These constitutively active Ras proteins contribute to malignant transformation (Bos, 1989; Lowy and Willumsen, 1993) .
Ras transformation requires Ras membrane anchorage (Hancock et al., 1989; James et al., 1993; Kohl et al., 1993; Willumsen et al., 1996) . Membrane association of the three common Ras proteins is promoted by their C-terminal S-farnesylcysteine carboxy methylesters and by a stretch of lysine residues in K-Ras 4B, or by the S-farnesylcysteine carboxy methylesters and two S-palmitoyl moieties in H-Ras and one palmitoyl moiety in N-Ras (Hancock et al., 1989; Willumsen et al., 1996) . The anchoring moieties of Ras proteins target them to the cell membrane (Choy et al., 1999) , where they are concentrated in lipid rafts or caveolae (Mineo et al., 1996; Roy et al., 1999; Song et al., 1996) . While S-palmitoyl or N-myristoyl moieties enhance partitioning of proteins into ordered lipid rafts the isoprenoid moiety disfavors such partitioning (Melkonian et al., 1999) . Thus, it is not yet clear how the branched and bulky structure of the farnesyl moiety supports interactions of Ras proteins with the cell membrane. Several experiments suggested that the farnesyl moiety might confer functional speci®city on Ras membrane interactions. For example, H-Ras modi®ed by an inappropriate isoprenoid (e.g. by the C 20 geranylgeranyl group) has transforming activity but not normal Ras function (Buss et al., 1989) . Other experiments showed that modi®cation of normal Ras by the fatty acid myristate ± but not by a farnesyl group ± results in activation of transforming activity, suggesting that N-myristoylated H-Ras (myr-H-Ras) cannot control normal Ras functions (Buss et al., 1989) .
Based on such studies we previously designed compounds resembling the farnesylcysteine of Ras and showed that among these compounds S-trans,-trans-farnesylthiosalicylic acid (FTS), but not its C10 geranyl analog (GTS), can dislodge farnesylated Ras but not myr-H-Ras from the membrane of intact cells, and can inhibit Ras-transforming activity in vitro and in vivo (Haklai et al., 1998; Kloog et al., 1999; Marom et al., 1995; Niv et al., 1999) . In addition,¯uorescence photobleaching recovery experiments showed that FTS interferes with the membrane association of GFP-KRas 4B(12V) and suggested the existence of transient interactions between GFP-K-Ras 4B(12V) and slowermoving domains or proteins (Niv et al., 1999) . Here we employed FTS to search for new Ras-interacting proteins that participate in Ras membrane anchorage and contribute to cell transformation.
Results

Identification of binding partners of Ras
With the object of temporarily`freezing' transient interactions of Ras with membrane-associated proteins we designed a procedure, using the reducible chemical cross-linker dithiobis (succinimidyl propionate) (DSP), in an attempt to isolate Ras-interacting proteins sensitive to FTS from membranes of H-Ras(12V)-transformed Rat-1 (EJ) cells. The particulate fractions (100 000 g pellet, P 100 ) of untreated and FTS-treated cells were exposed to DSP, and detergent extracts of these preparations were then screened for Rasimmunoreactive bands in immunoblots. We detected a prominent 34 ± 43 kDa Ras-immunoreactive band and several larger complexes in the P 100 fraction of EJ cell but not in the P 100 fraction of FTS-treated EJ cells ( Figure 1a , lanes 1 ± 3). Similar results were obtained when P 100 of EJ cell was exposed to FTS in vitro ( Figure 1a , lanes 4 and 5), consistent with a direct eect of the inhibitor on interactions between the mature Ras protein and membrane associated Rasinteracting proteins. Using MonoQ chromatography followed by a two-step gel puri®cation procedure, we isolated Ras-interacting proteins sensitive to FTS. The ®rst gel, under non-reducing conditions, separated the 34 ± 43 kDa Ras-adducts from other complexes ( Figure  1a , lane 6). The second gel, in the presence of the reducing reagent dithiothreitol (DTT), separated the Ras-interacting proteins from Ras, leading to their isolation ( Figure 1a , lane 8; Figure 1b) . Two major proteins, p14 (M r *14 kDa) and p17 (M r *17 kDa), were released by DTT from the 34 ± 43 kDa Rasimmunoreactive band (Figure 1b) , as expected of proteins that form complexes with the 21-kDa HRas(12V) protein. We repeated the above procedures using equal numbers of EJ cells, their parental Rat-1 cells, or myr-H-Ras(12V)-transformed Rat-1 cells, and detected only small amounts of the two Ras-interacting proteins, particularly p14 (Figure 1b ). This led us to suspect that p14 speci®cally binds the farnesylated HRas(12V) and may be involved in cell transformation induced by this Ras protein. By sequencing p14 we identi®ed it as rat galectin-1 (Figure 1c) , a b-galactoside-binding protein previously implicated in cell transformation (Andre et al., 1999; Barondes et al., 1994; Kopitz et al., 1998; Ohannesian et al., 1995; van den Brule et al., 1995; Wells and Mallucci, 1991; Yamaoka et al., 1991 Yamaoka et al., , 2000 . Speci®c anti galectin-1 antibody (Ab) (Kopitz et al., 1998; Yamaoka et al., 2000) con®rmed that p14 released by DTT from the 34 ± 43 kDa Ras-immunoreactive band is galectin-1 (Figure 1d ). Moreover, we repeated the cross-linking/ two-step gel procedure using an enriched plasma membrane preparation of EJ cells and found that both H-Ras(12V) and galectin-1 were released from the Ras immunoreactive 34 ± 43 kDa complex of the plasma membrane (Figure 1e ). These results suggest that HRas(12V) and galectin-1 interact in the cell membrane.
In additional experiments we immunoprecipitated speci®cally the cross-linked Ras-immunoreactive complexes with Ras Ab (Figure 2a , ®rst gel) and demonstrated that both the 21 kDa Ras and the 14 kDa galectin-1 proteins were released from the 34 ± 43 kDa Ras-immunoreactive band (Figure 2a , second gel). Together with the size of the cross-linked complex, which is equal to the sum of the molecular weights of Ras and galectin-1, these experiments demonstrate a direct binding interaction between the two proteins, which must be in close proximity to react with the cross-linking reagent. Moreover, a separate set of experiments demonstrated co-immunoprecipitation of H-Ras(12V) and galectin-1 even without crosslinking (Figure 2b ). In these experiments extracts of EJ cell membranes were subjected to immunoprecipita- (7) we identi®ed p14 in the second gel as galectin-1. (e) Using enriched plasma membranes (PM) prepared as detailed under Materials and methods and the cross-linking two-step gel procedure detailed above we found that H-Ras(12V) and galectin-1 were released by DTT from the 34 ± 43 kDa Ras immunoreactive complex. The immunoblots of the second gel with Ras Ab and galectin-1 Ab are shown tion with Ras Ab then immunoblotted with galectin-1 Ab or subjected to immunoprecipitation with galectin-1 Ab then immunoblotted with Ras Ab. These experiments provide then an additional support for interactions of H-Ras(12V) and galectin-1 and precludes the possibility that such interactions were induced by the cross-linker.
Galectin-1 exhibits specificity towards H-Ras(12V)
Although galectin-1 is a cytosolic protein that lacks a signal sequence for transport, it can be released from cells and bind extracellular glycosylated proteins (Andre et al., 1999; Hughes, 1999) . Our observations implied, however, that intracellular galectin-1 interacts with H-Ras(12V), since Ras is not exposed to the extracellular environment. This inference was further supported by cross-linking experiments with intact EJ cells. We found that both H-Ras(12V) and galectin-1 were released by DTT from complexes of 34 ± 43 kDa proteins of the intact cell membrane (Figure 2c ). Notably, Ras and galectin-1 were also released by DTT from Ras-immunoreactive complexes with Mr values higher than 34 ± 43 kDa (Figure 2c ), such as those already observed in the early puri®cation steps (Figure 1a ). These results are consistent with the possible existence of higher orders of H-Ras(12V)-galectin-1 complexes, including galectin-1 dimers (Barondes et al., 1994; Cho and Cummings, 1995; Wells and Mallucci, 1991) with Ras and Ras dimers (Inouye et al., 2000) with galectin-1. Consistent with the above noted observations, we found cross-linked galectin-1-H-Ras(12V) in membranes of cells treated with 100 mM lactose (Figure 2d ), known to prevent binding of galectin-1 to glycosylated proteins (Wells and Mallucci, 1991) . These results suggest that galectin-1-H-Ras(12V) interactions are independent of the extracellular sugar binding functions of galectin-1.
Next we examined whether Ras isoforms other than H-Ras(12V) can interact with galectin-1. This was done using the cross-linking/two-step gel procedure in cells transformed by H-Ras(12V) (Haklai et al., 1998) , KRas 4B(12V) , N-Ras(13V) , and myr-H-Ras (Haklai et al., 1998) . Each of these cell lines expressed signi®cant amounts of galectin-1 and overexpressed the corresponding Ras isoform ( Figure 3a) . We found that the amount of Ras released from the entire repertoire of Ras-immunoreactive complexes of the various cell lines was equivalent to the amounts of Ras expressed by the cells (Figure 3a ). There was signi®cant variation, however, in the amounts of galectin-1 released from the complexes of the various cells. Relatively large amounts of galectin-1 were released from complexes of H-Ras(12V) cells, signi®cantly smaller amounts from complexes of K-Ras 4B(12V) cells, and almost none from complexes of N-Ras(13V) or myr-H-Ras cells ( Figure 3a) . These results show that galectin-1 exhibits speci®city towards H-Ras(12V), although it can also interact to some extent with K-Ras(12V).
Galectin-1 is essential for membrane localization of H-Ras(12V)
The observation that galectin-1 can bind activated HRas raises the intriguing possibility that galectin-1 expression is required for the proper membrane anchorage of active Ras and for Ras signaling and transforming activity. Consistent with this possibility we found that the amounts of membrane-associated galectin-1 were 1.7-fold higher in EJ cells than in Rat-1 cells, and that FTS, but not its inactive analog GTS, reduced the levels of both membrane H-Ras(12V) (50%) and galectin-1 (70%) in EJ cells (Figure 3b ). To further examine a possible functional link between Ras and galectin, we used galectin-1 antisense RNA (gal-1 
Galectin-1 binds oncogenic H-Ras
A Paz et al antisense) to down-regulate galectin-1 expression (Yamaoka et al., 2000) in 293T cells (Figure 3c ). Control experiments showed that antisense to another galectin family member, galectin-3, did not reduce the levels of galectin-1 (Figure 3c ). We then examined the eect of gal-1 antisense on the cellular localization of Ras by using¯uorescence confocal microscopy to analyse 293T cells expressing GFP-H-Ras(12V), GFP-H-Ras(wt), GFP-K-Ras(12V), and GFP-N-Ras(13V). As in previous studies (Choy et al., 1999; Niv et al., 1999) , all Ras isoforms were found to be localized to the membrane, with some perinuclear localization, particularly of N-and H-Ras (Figures 4 and 6 ). Coexpression of GFP-H-Ras(12V) with gal-1 antisense resulted in a robust mislocalization of GFP-HRas(12V), which was now localized mainly to intracellular compartments rather than to the intact cell membrane (Figure 4a,b) . Antisense to galectin-3, did not aect the membrane localization of GFP-HRas(12V) (Figure 4b ). Statistical analysis revealed that the eect of gal-1 antisense on GFP-H-Ras(12V) localization as compared to the eects of vector control or of gal-3 antisense was highly signi®cant (see Figure 4b , legend). To validate that the eects on GFP-H-Ras(12V) localization occur in cells whose galectin-1 level was reduced we employed doubleuorescence microscopy ( Figure 5 ). These studies con®rmed that GFP-H-Ras(12V) was mislocalized from the plasma membrane in cells whose galectin-1 levels were downregulated by antisense gal-1 ( Figure  5 ). Scanning of 20 cells showed that GFP-H-Ras(12V) was mislocalized in 80% of the cells with reduced galectin-1 levels. In addition, we found that gal-1 antisense had no eect on the localization of GFP-HRas (wt), GFP-K-Ras (12V), or GFP-N-Ras(13V) (Figure 6 ). These ®ndings are consistent with the binding speci®city observed in the cross-linking/twostep gel assays and demonstrate that galectin-1 is essential for membrane localization of H-Ras (12V).
Galectin -1 triggers the Ras-ERK pathway and is essential for H-Ras transformation
We next examined the eects of galectin-1 expression on Ras and ERK. Expression of galectin-1 in 293T cells resulted in an increase both in endogenous membrane-bound Ras (153%) and in the amounts of Ras-GTP (253%, Figure 7a ). Concomitantly, phosphorylated (active) ERK increased as well (155%, Figure 7a ). Activation of Ras or of ERK by galectin-1 expression was not blocked by 100 mM lactose or by neutralizing galectin-1 Ab (Kopitz et al., 1998) (Figure  7b ) implying that neither the lectin function of galectin-1 nor extracellular galectin-1 were involved in Ras and ERK activation in this set-up. Thus, expression of galectin-1 apparently increased membrane association of Ras and triggered the Ras-ERK pathway, which is essential for Ras transformation (Shields et al., 2000) . We found that gal-1 antisense indeed inhibited Rat-1 cell transformation by H-Ras(12V) and that dominantnegative H-Ras(17N) inhibited Rat-1 cell transformation by galectin-1 (Figure 7c,d) .
Discussion
In this study we established a hitherto unrecognized link between H-Ras(12V) and galectin-1, members of two families of proteins known to be associated with human malignancies. Our results show that HRas(12V)-galectin-1 interactions are essential for membrane anchorage of H-Ras(12V) (Figure 4 ) and for its transforming activity (Figure 7 ). In agreement with Figure 3 Selective interactions of galectin-1 with H-Ras(12V) are disrupted by FTS and by antisense gal-1 RNA. (a) Using the cross-linking/two-step gel procedure we determined the Ras ± galectin-1 complexes in equal numbers of ®broblasts overexpressing oncogenic H-, K-, N-and myr-H-Ras isoforms (upper left panel). Endogenous levels of galectin-1 (gal-1) in total cell lysates were determined prior to cross-linking (upper right panel). The apparent amounts of Ras (left panels) and of galectin-1 (right panels) released from M r 34 ± 43, 43 ± 57, and 57 ± 90 kDa complexes by DTT in immunoblots of the second gels are shown. (b) Upper panel ± the amounts of particulate galectin-1 in total P 100 fraction of Rat-1 and EJ cells were determined using galectin-1 Ab as detailed under Materials and methods. Lower panel ± EJ cells were treated with FTS or with GTS as detailed under Materials and methods and the levels of Ras and galectin-1 then determined in P 100 fraction. (c) Galectin-1 antisense RNA reduces the amounts of galectin-1 in 293T cells. The cells were transfected with antisense gal-1 or with antisense gal-3 and the total amounts of galectin-1 were determined by immunoblotting with galectin-1 Ab Oncogene Galectin-1 binds oncogenic H-Ras A Paz et al previous studies (Yamaoka et al., 1996 (Yamaoka et al., , 2000 we ®nd that galectin-1 can transform rodent ®broblasts. Moreover, we show that dominant-negative Ras inhibits galectin-1 transformation (Figure 7) . Thus H-Ras transformation requires galectin-1 and galectin-1 transformation requires an active Ras pathway. These results and the observation that expression of galectin-1 triggered the Ras-ERK cascade in the presence of high lactose concentrations or of neutralizing galectin-1 Ab (Figure 7 ) demonstrate a functional link between intracellular galectin-1 and the membrane associated active Ras protein. These and the observed direct association of galectin-1 and H-Ras(12V) (Figure 2) suggest that intracellular galectin-1 stabilizes the interactions of H-Ras-GTP with the cell membrane, independent of its extracellular lectin function. Therefore, in addition to the well documented functioning of secreted galectin-1 as a b-galactoside-binding protein (Hughes, 1999) and of intracellular galectin-1 as a regulator of pre-mRNA splicing (Vyakarnam et al., 1997) , our results describe a new function of intracellular galectin-1 namely, the promotion of speci®c interaction of activated H-Ras with the cell membrane.
What could confer such high speci®city of galectin-1 to H-Ras(12V) and how can this speci®c interaction stabilize the active Ras in the cell membrane? Our results and other recent experiments provide some possible explanations. First, it seems most likely that it is Ras that recruits galectin-1 to the cell membrane and not vice versa since Ras, but not galectin-1, has membrane targeting signals. Second, we conclude that at least the farnesyl moiety of H-Ras(12V) is required for interactions with galectin-1 since myr-HRas(12V) did not interact with galectin-1. Third, the lack of an eect of galectin-1 antisense RNA on plasma membrane localization of GFP-H-Ras(wt) which is mostly inactive suggests that H-Ras-GDP does not require galectin-1 for its membrane association. Together, these notions are consistent with a concept that speci®city of galectin-1 towards activated H-Ras is determined by at least two factors: the farnesyl isoprenoid moiety and the GTP-bound conformation state of H-Ras. Since the GDP loaded H-Ras is a resident of membrane rafts (Mineo et al., 1996; Prior et al., 2001) and since H-Ras-GTP is segregated from lipid rafts (Prior et al., 2001) this hypothesis predicts that the active H-Ras-GTP would recruit galectin-1 to disordered membrane domains. Preliminary sucrose gradient¯otation experiments indeed demonstrate that galectin-1 is enriched in the heavy membrane fractions and not in the light (ordered) membrane raft fractions. We therefore suggest that galectin-1 interacts with the active form of H-Ras in a disordered membrane phase, perhaps stabilizing the farnesyl group of H-Ras-GTP. Consistent with this later possibility we ®nd that the farnesylcysteine mimetic FTS interferes with the interactions of H-Ras(12V) and galectin-1 (Figure 3) and destabilizes H-Ras(12V)-membrane interactions (Haklai et al., 1998) . The recent demonstration that the adjacent hypervariable sequence upstream of the farnesylcysteine of H-Ras is required for H-Ras-GTP localization outside of rafts and for Ras transformation (Prior et al., 2001) would suggest that this sequence may also be involved in H-Ras(12V)-galectin-1 interactions. If so this could explain the preferential interactions of galectin-1 with H-Ras(12V) over the other activated Ras isoforms.
H-Ras and galectin-1 are members of two families of proteins known to be associated with human malignancies (Andre et al., 1999; Barondes et al., 1994; Bresalier et al., 1997; Hadari et al., 2000; Kopitz et al., 1998; Ohannesian et al., 1995; Polyak et al., 1997; van den Brule et al., 1995; Wells and Mallucci, 1991; Yamaoka et al., 1991 Yamaoka et al., , 2000 . Perhaps it is not less important to note that both Ras proteins (Bar-Sagi and Hall, 2000; Downward, 1998; Shields et al., 2000) and galectins (Hughes, 1999; Perillo et al., 1998) , share in common a number of regulatory activities including regulation of cell growth, apoptosis, cell adhesion cell migration and metastasis. It is also interesting that the cell type and the cellular background are important determinants for the activities of Ras (Bar-Sagi and Hall, 2000; Downward, 1998; Shields et al., 2000) and of galectins (Allione et al., 1998; Hughes, 1999; Perillo et al., 1998; Vespa et al., 1999) such that both can act, for example, as pro-or anti-apoptic molecules and as regulators of cell proliferation or of cell senescence. Our results along with the previous knowledge of galectins suggest that some of the common regulatory activities of H-Ras and galectin-1 are likely to be associated with a combined action of the galectin-1 extracellular lectin functions and of the direct interaction between the two proteins. Finally, the high speci®city of galectin-1 towards activated H-Ras raises the attractive possibility of new strategies for cancer therapy.
Materials and methods
Identification of binding partners of Ras
We prepared cell membranes (100 000 g pellets) from control and FTS-treated (50 mM, 24 h) EJ cells and resuspended them in 3 ± 15 ml of 10 mM sodium bicarbonate, pH 8.5 (*1.5 mg protein/ml) (Haklai et al., 1998) . We quanti®ed Ras immunoreactivity by immunoblotting (Haklai et al., 1998; Niv et al., 1999) using 1 : 2500 dilution of pan Ras Ab (Ab-3 Calbiochem, 0.1 mg/ml). After incubation of the membranes (6 min, 48C) with 300 mM DSP (Pierce), the reaction was quenched with 20 mM Tris ± HCl, pH 8.5, and the crosslinked proteins were extracted (20 min, 48C) with 0.05% Triton X-100. The extracted proteins (containing 490% of Ras and the Ras adducts) were then resolved on a MonoQ column (5 ml HiTrap Q column Pharmacia) and eluted with a linear NaCl gradient (0.0 ± 0.7 M). The active fractions (eluted at 0.3 ± 0.4 M NaCl) were pooled, proteins precipitated with 20% trichloroacetic acid/0.01% sodium cholate, resuspended with 1 ml acetone, and reprecipitated. The pellet was dissolved in SDS sample buer containing 8 M urea without any reducing reagent and the proteins were fractionated on 12.5% gels by SDS ± PAGE (®rst gel). The protein bands corresponding to the Ras-immunoreactive complexes were excised. Each gel slice was incubated in 20 ml of SDS sample buer containing 50 mM DTT (608C, 30 min) and resolved on a second 12.5% gel (second gel). Proteins were visualized by silver or Coomassie brilliant blue staining. The Coomassie-stained p14 was analysed by microsequencing at the Technion Protein Center (Haifa, Israel). The second gels were also used for immunoblotting with pan-Ras Ab (Haklai et al., 1998) and/or with 2 mg/ml rabbit anti-galectin-1 Ab (Kopitz et al., 1998; Yamaoka et al., 2000) . Ras-galectin-1 complexes were immunoprecipitated from the entire MonoQ pool of cross-linked preparations or from Triton X-100 extracts of EJ cell membranes without cross-linking using pan-Ras Ab (2 mg) and protein GSepharose or galectin-1 Ab (20 mg) and protein A-Sepharose (Haklai et al., 1998) . Samples used for immunoprecipitation were ®rst precleared using 1 mg naive mouse IgG and protein A-Sepharose (for IP of Ras) or 2 mg naive rabbit serum and protein A-Sepharose (for IP of galectin-1) as detailed previously (Marom et al., 1995) . We repeated the above cross-linking/two-step gel procedure with various cell lines under the same analytical scale conditions, in each case screening all MonoQ column fractions and then pooling the entire peak of the Ras immunoreactive complexes. We also used the cross-linking/two-step gel procedure to analyse Ras-galectin-1 complexes in intact EJ cells and in the plasma membrane. Cross-linking on live cells was performed on ice (2610 5 cells in PBS, pH 7.5, 125 mM DSP). The cells were then processed as described above, omitting the MonoQ step. Enriched plasma membranes were prepared as detailed previously (Smart et al., 1995) . Brie¯y, EJ cells were homogenized with a Dounce homogenizer in 0.25 M sucrose, 1 mM EDTA, 120 mM Tricine pH 7.8 and the homogenates were subjected to dierential centrifugation followed by a Percoll gradient (Smart et al., 1995) . The plasma membrane band was collected, washed with 10 mM sodium bicarbonate, pH 8.5 and resuspended in the same buer. These plasma membrane preparations were then used for the cross-linking/two-step gel experiments as detailed above.
Preparation of cDNAs and plasmids
We cloned the entire coding sequence of rat galectin-1 cDNA from total RNA of EJ cells, using the 5'-AAGGCTTCCA-TGGCCTGTGGTCTGGTCGCCAGC-3' and 3'-GGGGTA-CCCTTCACTCAAAGGCCACACAC-5' primers in a RT ± PCR ampli®cation system (ACCESS RT ± PCR, Promega). The PCR product was cloned into pGEM-T easy vector (Promega) and sub-cloned into the KpnI and HindIII sites (sense orientation, pc-gal-1) or into the NotI site (antisense orientation, pc-gal-1 antisense) of the pcDNA3 expression vector. We cloned the entire coding sequence of galectin-3 from total RNA of human macrophages using the 5'-TAT-AGAATTCAAATGGCAGACAATTTTTCGC-3' and 3'-T-ATAGAATTCGATTATATCATGGTATATGAAGC-5' and the above RT ± PCR ampli®cation system. The PCR product was restricted by EcoRI and cloned into the EcoRI site in pcDNA3. The orientation and sequence of the galectin-3 sense and galectin-3 antisense (pc-gal-3 antisense) were con®rmed by DNA sequencing. The vectors pDCR-HRas(12V) and pZIP-H-Ras(wt) were a gift from AD Cox, pRSV-H-Ras(17N) was a gift from Y Yarden. pcDNA3-NRas(13V) and pcDNA3 myr-H-Ras were described (Haklai et al., 1998) . GFP ± Ras cDNAs were generated by insertion of the entire coding sequences of H-Ras(12V), H-Ras(wt), KRas(12V) or N-Ras(13V) into pEGFP-C3 (Clontech), as described previously (Niv et al., 1999) . All DNA sequences were con®rmed by DNA sequencing.
Transfections and transformation assays
293T cells were transfected transiently by the calcium phosphate method using 2610 5 cells and 5 mg DNA. Cells were co-transfected with DNA in the ratio of 1/3 Ras vectors and 2/3 pc-gal-1 or pc-gal-3 antisense or 1/3 pc-gal-1 and 2/3 pRSV-H-Ras(17N). The appropriate empty vectors were used for control co-transfections. Transformation of Rat-1 cells was assayed as described previously (Clark et al., 1995) by counting foci 3 weeks after transfection in triplicate dishes stained with crystal violet.
Biochemical procedures and confocal microscopy
Ras ± GTP (in 1000 mg protein of cell lysate) was measured by the Ras-RBD assay (Herrmann et al., 1995) . The amount of ERK protein (anti ERK Ab, Santa Cruz) and activated ERK (anti-phosphorylated ERK Ab, Sigma) were quanti®ed by immunoblotting (30 mg protein). We transfected 293T cells plated on glass coverslips with the GFP-Ras isoforms as detailed above and analysed them by¯uorescence confocal microscopy as described previously (Niv et al., 1999) . In some experiments we also labeled the cells with the membrane lipid probe R18 (Molecular Probes). Single or dual¯uorescence images (green¯uorescence for GFP, red uorescence for R18) were collected on a Zeiss LSM 410 confocal microscope ®tted with¯uorescein and rhodamine ®lters (Niv et al., 1999) . We also performed doubleuorescence experiments with GFP-H-Ras(12V) and galectin-1 Ab. In these experiments 293T cells were co-transfected with GFP-H-Ras(12V) and pc-gal-1 antisense or vector control as detailed above and the cells were then ®xed and permeabilized. Fixation was in PBS containing 4% paraformaldehyde, followed by permeabilization with 0.5% Triton X-100. The samples were blocked with 2% bovine serum albumin and 200 mg/ml goat gamma globulin (30 min). Labeling with galetin-1 Ab was by successive incubations with: (i) 5 mg/ml anti galectin-1 Ab; (ii) 5 mg/ml biotin-goat anti rabbit IgG (Jackson Immuno-Research); (iii) 0.5 mg/ml Cy3-streptavidin (Jackson Immuno-Research). All incubations were for 45 min at 228C, with three extensive washes after each step. Background staining was obtained on samples where galectin-1 Ab was omitted. Dual uorescence digital images were recorded as detailed above (green¯uorescence for GFP, red¯uorescence for Cy3).
